Welcome
Support Centre
21 March 2013 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ Print-friendly version ]
A randomised trial of paclitaxel combined with platinum-based chemotherapy vs conventional platinum-based chemotherapy in the treatment of women with ovarian cancer
ISRCTN ISRCTN47434271
DOI 10.1186/ISRCTN47434271
ClinicalTrials.gov identifier NCT00002894
EudraCT number
Public title A randomised trial of paclitaxel combined with platinum-based chemotherapy vs conventional platinum-based chemotherapy in the treatment of women with ovarian cancer
Scientific title
Acronym N/A
Serial number at source ICON4
Study hypothesis To compare paclitaxel combined with platinum to a control arm of conventional platinum-based chemotherapy in the treatment of women with recurrent ovarian cancer.
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment International
Disease/condition/study domain Ovarian cancer
Participants - inclusion criteria 1. Recurrent epithelial ovarian cancer previously treated with chemotherapy
2. Treatment free interval of at least 6 months
Participants - exclusion criteria Does not meet inclusion criteria
Anticipated start date 01/03/1996
Anticipated end date 31/03/2002
Status of trial Completed
Patient information material
Target number of participants 800 in 5 countries
Interventions Paclitaxel combined with platinum and the other group receives platinum-based chemotherapy (with no paclitaxel)
Primary outcome measure(s) 1. Survival time
2. Quality of life
3. Health economics
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Medical Research Council (MRC) (UK)
Trial website
Publications 2003 results in http://www.ncbi.nlm.nih.gov/pubmed/12826431
Contact name Ms  Claire  Amos
  Address MRC Clinical Trials Unit
222 Euston Road
  City/town London
  Zip/Postcode NW1 2DA
  Country United Kingdom
Sponsor Medical Research Council (MRC) (UK)
  Address 20 Park Crescent
  City/town London
  Zip/Postcode W1B 1AL
  Country United Kingdom
  Tel +44 (0)20 7636 5422
  Fax +44 (0)20 7436 6179
  Email clinical.trial@headoffice.mrc.ac.uk
  Sponsor website: http://www.mrc.ac.uk
Date applied 06/04/2000
Last edited 02/07/2009
Date ISRCTN assigned 06/04/2000
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2013 ISRCTN unless otherwise stated.